(Q34422248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

title

Pulmonary exacerbations and parent-reported outcomes in children <6 years with cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

6

Alexandra L Quittner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

author name string

Lyndia C Brumback

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Arthur Baines

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Stephanie D Davis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Stephen L Daniel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Margaret Rosenfeld

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

ISIS Study Group

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

publication date

29 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

published in

Pediatric Pulmonology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

page(s)

236-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age.

16 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

Cystic fibrosis pulmonary exacerbations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

Defining a pulmonary exacerbation in cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

Predictive 5-year survivorship model of cystic fibrosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213320

Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality.

6 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23056

Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23056

Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23056

Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23056

Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23056

Pulmonary exacerbations in CF patients with early lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23056

Risk Factors for Bronchiectasis in Children with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23056

Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24777957

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pulmonary exacerbations in cystic fibrosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24777957

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/PPUL.23056

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777957%20AND%20SRC:MED&resulttype=core&format=json